Advanced Neuromodulation Systems Assigned Patent for Neural Stimulation for Treatment of Metabolic Syndrome and Type 2 Diabetes
Copyright © Targeted News Service, 2014
2014-09-23
Copyright © Targeted News Service, 2014
2014-09-23
ALEXANDRIA, Va., Sept. 23 -- Advanced Neuromodulation Systems, Plano, Texas, has been assigned a patent (8,838,231) developed by John D. Dobak III, La Jolla, California, for "neural stimulation for treatment of metabolic syndrome and type 2 diabetes."
The patent application was filed on June 3, 2011 (13/152,777). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s . . .
The patent application was filed on June 3, 2011 (13/152,777). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s . . .